CVE-2024-6333

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

1.16% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 64.7% of scored records. A rank, not a probability.

NVD base score

7.2 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Deferred. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2024-10-17 13:51Z1 YR AGO

Last updated

2025-09-17 16:52Z11 MO AGO

Reserved

2024-06-25

Assigning CNA

Xerox

Record state

PUBLISHED

Severity

High (CVSS 7.2)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Weaknesses

• CWE-77Improper Neutralization of Special Elements used in a Command ('Command Injection')Class
• CWE-78Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection')Base

Data version

5.1

Document digest

197842fbf3351c4e693d42fad86bbd626529ed7be455bc9200e791dfc32ff2af

• securitydocs.business.xerox.comhttps://securitydocs.business.xerox.com/wp-content/uploads/2024/10/Xerox-Security-Bulletin-XRX24-015-for-Altalink-Versalink-and-WorkCentre-%E2%80%93-CVE-2024-6333-.pdf
• seclists.orghttp://seclists.org/fulldisclosure/2024/Oct/17